NEAT1 and Alzheimer disease: The results showed that plasma level of NEAT1 could efficiently discriminate MCI (AUC=0.78, CI; 0.619-0.942, p=0.004) with 60 % sensitivity and 91 % specificity and ad-AD (AUC=0.78, CI; 0.647-0.926, p=0.001) with 73 % sensitivity and 71 % specificity from controls (Figure 5b, c(Fig. 5)).